Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17 , 9509.

Authors :: Fusco V
Alessio M
Guglielmini PF
Vincenti M
Fasciolo A
Rossi M
Source :: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Sep 27; Vol. 18 (19). Date of Electronic Publication: 2021 Sep 27.
Publication Year :: 2021
Abstract: Marcianò et al. launched an alert in this journal about a possible association between medication-related osteonecrosis of the jaws (MRONJ) and cyclin-dependent kinase (CDK) 4/6 inhibitors in breast cancer patients [...].

Subjects :: Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinases
Humans
Jaw
Public Health
Bisphosphonate-Associated Osteonecrosis of the Jaw epidemiology
Bisphosphonate-Associated Osteonecrosis of the Jaw etiology
Bone Density Conservation Agents

Language :: English
ISSN :: 1660-4601
Volume :: 18
Issue :: 19
Database :: MEDLINE
Journal :: International journal of environmental research and public health
Publication Type :: Academic Journal
Accession number :: 34639444
Full Text :: https://doi.org/10.3390/ijerph181910143